Clinical Trial Update: Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating Biomed 101 in combination with interleukin-2 for kidney cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• Biomed 101
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: BioMedicines | Conditions: Drug Extravasation, Kidney Cancer | Phase 1 | Status: COMPLETED